Andrew LamManaging Director, Head of Biotech Private Equity at Ally Bridge GroupSpeaker
Agenda Sessions
Capital Currents: Navigating the Waves of Healthcare Investment in 2025
, 9:00amView SessionNavigating the Path to IPO: Preparing Your Biotech Company for the Public Markets
, 1:45pmView Session